Video

Prostate Cancer Screening and Early Detection, Part I

With multiple new therapies entering the prostate cancer arena the continued emphasis has been placed on developing pathways to help identify, treat, and monitor patients. However, identifying early-stage patients who are likely to fail definitive therapy remains troublesome, since there are no firm guidelines or protocols. Additionally, the recent controversial recommendation from the United States Preventive Service Task Force (USPSTF) on PSA screening has added further complications.

E. David Crawford, MD, believes the bottom-line of the USPSTF decision on PSA screening is that diagnosis and treatment need to be separated to avoid treating early-stage patients who do not need therapy. Pathways need to be developed that accurately identify the individuals who need to be screened and treated, to avoid overdiagnosis and overtreatment. Additionally, Crawford suggests screening can be done less frequently and can be reduced from once a year to as infrequently as every five years.

View >>> Prostate Cancer Screening and Early Detection, Part II.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity